NDUVRA
NDUVRA
Approved
DIN Number
02448254
Drug Class
Human
Market Date
N/A
Company
HC
Dermavant Sciences GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02448254
AIG Number0266685001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D05AX07 TAPINAROF
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification84:24.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
TAPINAROFActive
Strength: 1 % / W/W
Monograph: TAPINAROF